Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma

BACKGROUND: The introduction of immune checkpoint inhibitors has led to a survival benefit in patients with advanced melanoma; however data on the adoption of immunotherapy in the community are scarce. METHODS: Using the National Cancer Database, we identified 4725 patients aged ≥20 diagnosed with m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunother Cancer
Main Authors: Krimphove, Marieke J., Tully, Karl H., Friedlander, David F., Marchese, Maya, Ravi, Praful, Lipsitz, Stuart R., Kilbridge, Kerry L., Kibel, Adam S., Kluth, Luis A., Ott, Patrick A., Choueiri, Toni K., Trinh, Quoc-Dien
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836520/
https://ncbi.nlm.nih.gov/pubmed/31699149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0782-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares